Application no. and date | 21720012.0 (espacenet) (Federated) (European Patent Register), 20210401 | Patent/reg. no. and date | DK/EP 4125903, 20241009 | Publication date | 20230208 | Priority no. and date | US 202063003544 P, 20200401 | EP pub. no. and date |
EP 4125903 20230208 | Effective date | | Applicant/owner | Otsuka Pharmaceutical Co., Ltd., 2-9, Kanda Tsukasa-machi Chiyoda-ku
Tokyo 101-8535, JP | Applicant ref. no. | | Inventor | HARLIN, Matthew, c/o OTSUKA PHARMACEUTICAL CO., LTD., 3-2-27, Otedori, Chuo-ku
Osaka-shi, Osaka 540-0021, JP, WANG, Xiaofeng, c/o OTSUKA PHARMACEUTICAL CO., LTD., 3-2-27, Otedori, Chuo-ku
Osaka-shi, Osaka 540-0021, JP, WANG, Yanlin, c/o OTSUKA PHARMACEUTICAL CO., LTD., 3-2-27, Otedori, Chuo-ku
Osaka-shi, Osaka 540-0021, JP, RAOUFINIA, Arash, c/o OTSUKA PHARMACEUTICAL CO., LTD., 3-2-27, Otedori, Chuo-ku
Osaka-shi, Osaka 540-0021, JP | Representative | | Opponent | | IPC Class | A61K 31/496 (2006.01) , A61P 25/18 (2006.01) | Title | METHODS FOR DOSE INITIATION OF ARIPIPRAZOLE TREATMENTS | Int. application no. | JP2021014194 | Int. publication no. | WO2021201239 | Related patent (certificate) | | Status | Enhedspatent registreret | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|